Understanding how T-cell receptors influence T-cell lymphoma progression
THE T-CELL RECEPTOR'S ROLE IN T-CELL LYMPHOMA PATHOGENESIS
This study is looking at how certain immune cells called T-cells behave in T-cell lymphoma, especially how they interact with other cells in the tumor environment, to find new ways to improve treatment options for patients.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11014942 on NIH RePORTER |
What this research studies
This research investigates the role of T-cell receptors in T-cell lymphoma (TCL) and how they contribute to the disease's progression and resistance to chemotherapy. The study focuses on the tumor microenvironment, particularly the interaction between malignant T cells and antigen-presenting cells, such as lymphoma-associated macrophages. By examining the mechanisms of T-cell activation and the role of specific transcription factors like GATA-3, the research aims to uncover new insights into TCL and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with T-cell lymphoma who are experiencing disease progression or chemotherapy resistance.
Not a fit: Patients with other types of lymphoma or those who are not currently undergoing treatment for T-cell lymphoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients with T-cell lymphoma, potentially overcoming chemotherapy resistance.
How similar studies have performed: Previous research has shown promising results in understanding the role of T-cell receptors in cancer, suggesting that this approach may yield valuable insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Wilcox, Ryan a — University of Michigan at Ann Arbor
- Study coordinator: Wilcox, Ryan a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.